Whitnell & Co’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-200
Closed -$18K 272
2019
Q2
$18K Sell
200
-23
-10% -$1.95K 0.01% 217
2019
Q1
$19K Hold
223
0.01% 217
2018
Q4
$17K Sell
223
-999
-82% -$77.8K 0.01% 211
2018
Q3
$94K Sell
1,222
-111
-8% -$8.21K 0.04% 158
2018
Q2
$90K Hold
1,333
0.04% 155
2018
Q1
$97K Hold
1,333
0.04% 152
2017
Q4
$100K Buy
1,333
+111
+9% +$8.38K 0.04% 153
2017
Q3
$94K Hold
1,222
0.04% 154
2017
Q2
$91K Hold
1,222
0.04% 149
2017
Q1
$81K Sell
1,222
-151
-11% -$10.1K 0.04% 156
2016
Q4
$90K Sell
1,373
-201
-13% -$13K 0.04% 154
2016
Q3
$111K Hold
1,574
0.04% 151
2016
Q2
$116K Buy
1,574
+201
+15% +$13.9K 0.04% 156
2016
Q1
$89K Sell
1,373
-170
-11% -$11.6K 0.03% 162
2015
Q4
$119K Hold
1,543
0.04% 154
2015
Q3
$127K Buy
1,543
+321
+26% +$28.6K 0.05% 147
2015
Q2
$108K Buy
1,222
+580
+90% +$53.2K 0.04% 154
2015
Q1
$57K Hold
642
0.02% 178
2014
Q4
$53K Buy
642
+419
+188% +$34.7K 0.02% 192
2014
Q3
$19K Sell
223
-168
-43% -$13.6K 0.01% 215
2014
Q2
$32K Sell
391
-613
-61% -$48.2K 0.01% 202
2014
Q1
$77K Buy
1,004
+167
+20% +$12.2K 0.04% 170
2013
Q4
$60K Sell
837
-167
-17% -$11.6K 0.03% 178
2013
Q3
$69K Sell
1,004
-56
-5% -$3.71K 0.03% 171
2013
Q2
$67K Buy
+1,060
New +$69K 0.03% 177

Other funds holding NVS

Whitnell & Co's NVS Position: Q3 2019 in Review

Whitnell & Co sold out of Novartis (NVS) in Q3 2019, closing a stake of 200 shares — an estimated $18K sold.

Whitnell & Co first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $127K in Q3 2015. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Whitnell & Co reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Whitnell & Co sold 200 Novartis shares in Q3 2019, an estimated $18K.
  • Whitnell & Co first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
  • Whitnell & Co's Novartis position peaked at $127K in Q3 2015.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Whitnell & Co's 13F filing for Q3 2019, filed 5 Nov 2019.